Ligand · 8VG
8VG · 5-[[(5~{S})-6-[[(1~{S})-1-(4-hydroxyphenyl)-2-oxidanylidene-2-(prop-2-ynylamino)ethyl]amino]-6-oxidanylidene-5-[[4-[3-(trifluoromethyl)-1,2-diazirin-3-yl]phenyl]carbonylamino]hexyl]amino]-5-sulfanylidene-pentanoic acid
8VG, 5-[[(5~{S})-6-[[(1~{S})-1-(4-hydroxyphenyl)-2-oxidanylidene-2-(prop-2-ynylamino)ethyl]amino]-6-oxidanylidene-5-[[4-[3-(trifluoromethyl)-1,2-diazirin-3-yl]phenyl]carbonylamino]hexyl]amino]-5-sulfanylidene-pentanoic acid (C31 H33 F3 N6…
- Component
- 8VG
- Formula
- C31 H33 F3 N6 O6 S
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
8VG in 1 structure; the first of them:
- 7X3P · Crystal structure of human SIRT5 in complex with diazirine inhibitor 9 · 8VG A401 · binds THR69, ARG71, ALA82, GLN83, ALA86, PHE101, TYR102, ARG105 and 15 more
Residues it binds most
VAL 1, ALA 1, ARG 1, GLN 1, PHE 1, TYR 1, ASN 1, GLU 1, GLY 1, HIS 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.